Chemical Science symposia on sustainable energy

CARRI COTTON. | October 19, 2018

article image
Registration is now open for our Chemical Science symposia, which are to be held in two locations in China (Harbin and Xiamen) in December. The NSFC-RSC International Symposium on Energy Chemistry will be held in Harbin, China from 7th-9th of December, you can register now here. The Chemical Science Symposium on Sustainable Energy will be held in Xiamen, China on 10th of December, you can register now here. The theme of the Chemical Science Symposium will be renewable energy and sustainability, bringing together leading researchers in the field of energy science and related subjects.

Spotlight

Amneal Pharmaceuticals

Amneal Pharmaceuticals is the fifth largest generic pharmaceutical manufacturer in the United States and the fastest growing generic company globally, according to IMS Health. Founded in 2002 in the United States by brothers Chirag and Chintu Patel, the company has since grown to include offices in Australia, Europe and Asia. Amneal’s diversified portfolio includes high quality complex dosage forms, such as liquids, topicals, transdermals, injectables, and inhalation products. As Amneal continues to experience unprecedented growth, its focus on quality, superb service levels, and building strong relationships holds firm and stands as testament to the strength of its reputation.

OTHER ARTICLES

Removal of non-industrial chemicals from the NICNAS Inventory

Article | March 23, 2020

The Australian Government announced its intention to implement reforms to the way in which industrial chemicals are regulated. The reforms are intended to streamline the process of assessing industrial chemicals to reduce the regulatory burden and to make regulatory effort more proportionate to risk. The Industrial Chemicals Act, which was passed by Parliament in February of 2019 and received Royal Assent in March of 2019, creates a new framework for the regulation of imported or manufactured industrial chemicals. The new scheme, referred to as the Australian Industrial Chemicals Introduction Scheme, or AICIS, will replace the current National Industrial Chemicals Notification and Assessment Scheme, referred to as NICNAS.

Read More

Optimizing chemical production using data-driven, AI-enabled hybrid modeling

Article | March 13, 2020

Smart use of your plant’s data can take process efficiency to a higher level. Hybrid models driven by artificial intelligence deliver the best results for the least effort. And you don’t need a data science degree to enjoy them. Data is everywhere these days – and the volumes of it are growing exponentially all the time. We’re used to smart uses of it in our everyday lives. Like Amazon and Netflix using our past behavior to tempt us with new products or shows, even making them more appealing by tailoring how they look based on carefully constructed, data-driven profiles of our tastes. Much of that heavy lifting is done by artificial intelligence (AI). In chemical production, process control systems have been collecting data measurements during continuous or batch manufacturing for decades.

Read More

The multi-million dollar polymers opportunity: continued big regional price differentials

Article | June 29, 2021

POLYMER BUYERS outside northeast (NEA) and southeast Asia (SEA) have a big opportunity to save millions of dollars on procurement costs during the rest of this year through purchasing more from the two regions.The opportunity has arisen because I believe that NEA and SEA polymer prices will remain very cheap relative to most of the world until at least the end of 2021. NEA comprises China, Japan, Taiwan and South Korea. Our definition of the SEA region is Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand and Vietnam.NEA and SEA producers can also make a lot of money by constantly monitoring and acting on strong arbitrage opportunities in other regions. As supply disruptions in the US look likely to continue, Europe and South & Central America seem particularly good opportunities for both buyers and producers.Before we discuss why I see NEA and SEA remaining cheap relative to most of the rest of the world until at least the end of the year, let us consider in more detail the size of the prize, starting with the resin buyers.

Read More

The Trump EPA’s “Working Approach” to new chemical reviews is only working for the chemical industry

Article | February 23, 2020

The Trump EPA has worked very hard to render this long-awaited update of its approach to reviewing new chemicals under TSCA an empty exercise. Despite Administrator Wheeler’s promises in January 2019 to the contrary: EPA has still failed to provide any legal or scientific justification for its Working Approach. EPA provided no actual response to the many detailed comments it received on its 2017 framework, instead issuing a 1.5-page document that dismisses many of the comments merely as having “stemmed from a misunderstanding of the Agency’s intent.”

Read More

Spotlight

Amneal Pharmaceuticals

Amneal Pharmaceuticals is the fifth largest generic pharmaceutical manufacturer in the United States and the fastest growing generic company globally, according to IMS Health. Founded in 2002 in the United States by brothers Chirag and Chintu Patel, the company has since grown to include offices in Australia, Europe and Asia. Amneal’s diversified portfolio includes high quality complex dosage forms, such as liquids, topicals, transdermals, injectables, and inhalation products. As Amneal continues to experience unprecedented growth, its focus on quality, superb service levels, and building strong relationships holds firm and stands as testament to the strength of its reputation.

Events